Publications by authors named "Aaron Schimmer"

Claim this Profile
R
Real-world experience with CPX-351 for secondary acute myeloid leukaemia: Comparison with FLAG-IDA in a propensity score matching analysis.
Maria Agustina Perusini, Ana Flavia Patiño, Claire Andrews, Sarit E Assouline, Joseph M Brandwein, Aaron D Schimmer

Br J Haematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial.
Guillaume Richard-Carpentier, Gopila Gupta, Charina Koraksic, Severine Cathelin, Lisa Wang, Aaron D Schimmer

Lancet Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A qualitative study of Emotion and Symptom-focused Engagement (EASE): An integrated psychotherapeutic and early palliative care intervention for patients with acute leukemia.
Kathryn Hunt, Laura Foran, Carmine Malfitano, Anne Rydall, Stephanie Nanos, Aaron D Schimmer

Support Care Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Risk Factors and Outcome for CNS Involvement in AML.
Jack T Seki, Georgina S Daher-Reyes, Eshetu G Atenafu, Jad Sibai, Aniket Bankar, Aaron Schimmer

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?
Akhil Rajendra, Elliot Smith, Eshetu G Atenafu, Aniket Bankar, Steven Chan, Aaron Schimmer

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.
Akhil Rajendra, Elliot Smith, Maria Agustina Perusini, Kenny Tang, Eshetu G Atenafu, Aaron D Schimmer

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia.
Tracy Murphy, Boyang Zhang, Tong Zhang, Ian King, Jose-Mario Capo-Chichi, Aaron D Schimmer

Haematologica· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin reduces the competitive advantage of Dnmt3a HSPCs.
Mohsen Hosseini, Veronique Voisin, Ali Chegini, Angelica Varesi, Severine Cathelin, Aaron D Schimmer

Nature· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOCS1 Protects Acute Myeloid Leukemia against Allogeneic T Cell-Mediated Cytotoxicity.
Enoch Tin, Sergio Rutella, Ismat Khatri, Yoosu Na, Yongran Yan, Aaron D Schimmer

Blood Cancer Discov· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase 2 study to assess the role of single-agent nivolumab to maintain remission in acute myeloid leukemia.
Athalia R Pyzer, Laura W Dillon, Elad Sharon, Theodore G Karrison, Yuanyuan Zha, Aaron D Schimmer

Blood Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia drug-tolerant persister cells survive chemotherapy by transiently increasing plasma membrane rigidity, that also increases their sensitivity to immune cell killing.
Yael Morgenstern, JongBok Lee, Yoosu Na, Brandon Y Lieng, Nicholas S Ly, Aaron D Schimmer

Haematologica· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia mitochondria hydrolyze ATP to support oxidative metabolism and resist chemotherapy.
James T Hagen, McLane M Montgomery, Raphael T Aruleba, Brett R Chrest, Polina Krassovskaia, Aaron D Schimmer

Sci Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of allosteric activation in human mitochondrial ClpP protease.
Monica M Goncalves, Adwaith B Uday, Taylor J B Forrester, S Quinn W Currie, Angelina S Kim, Aaron D Schimmer

Proc Natl Acad Sci U S A· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis.
Kira A Young, Mohsen Hosseini, Jayna J Mistry, Claudia Morganti, Taylor S Mills, Aaron D Schimmer

Nat Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed Refinement of 2022 European LeukemiaNet Adverse-Risk Group of AML Patients Using a Real-World Cohort.
Collins Wangulu, Davidson Zhao, Qianghua Zhou, Cuihong Wei, Rajat Kumar, Aaron Schimmer

Cancers (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serine phosphorylation facilitates protein degradation by the human mitochondrial ClpXP protease.
Yue Feng, Monica M Goncalves, Yulia Jitkova, Alexander F A Keszei, Yongran Yan, Aaron D Schimmer

Proc Natl Acad Sci U S A· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of scientific research-centralized expertise and specialization through full-service core facilities.
James Jonkman, Troy Ketela, Nhu-An Pham, Nikolina Radulovich, Genevieve Gasmi-Seabrook, Aaron D Schimmer

Biochem Cell Biol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.
Maria Agustina Perusini, Claire Andrews, Eshetu G Atenafu, Vikas Gupta, Dawn Maze, Aaron D Schimmer

Hematology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of adolescents and young adult acute myeloid leukemia patients compared with middle-aged patients: A single centre retrospective experience.
RuiQi Chen, Mohaned AlHumaid, Georgina Daher-Reyes, Eshetu G Atenafu, Steven Chan, Aaron D Schimmer

Leuk Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia mitochondria hydrolyze ATP to resist chemotherapy.
James T Hagen, Mclane M Montgomery, Raphael T Aruleba, Brett R Chrest, Thomas D Green, Aaron D Schimmer

bioRxiv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1-mutated AML.
Elliot Smith, Eshetu G Atenafu, Aniket Bankar, Steven Chan, Marta Davidson, Aaron Schimmer

Eur J Haematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiles and outcomes in de novo versus therapy-related core binding factor AML.
May Chiu, Aaron D Schimmer, Andre C Schuh, Aniket Bankar, Guillaume Richard-Carpentier

Blood Cancer J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol.
Maria Agustina Perusini, Claire Andrews, Atenafu G Eshetu, Vikas Gupta, Dawn Maze, Aaron D Schimmer

Leukemia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.
Hiroki Akiyama, Ran Zhao, Lauren B Ostermann, Ziyi Li, Matthew Tcheng, Aaron D Schimmer

Leukemia· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival and functional outcomes of critically ill patients with hematologic malignancies: a Canadian multicenter prospective study.
Laveena Munshi, Guillaume Dumas, Bram Rochwerg, Farah Shoukat, Michael Detsky, Aaron Schimmer

Intensive Care Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis